vs
IMMUCELL CORP（ICCC）与Valaris Ltd（VAL）财务数据对比。点击上方公司名可切换其他公司
IMMUCELL CORP的季度营收约是Valaris Ltd的1.1倍（$5.5M vs $5.2M），Valaris Ltd净利率更高（13798.1% vs -2.5%，领先13800.6%），Valaris Ltd同比增速更快（405.9% vs -8.4%），IMMUCELL CORP自由现金流更多（$-1.8M vs $-34.1M），过去两年Valaris Ltd的营收复合增速更高（29.5% vs 3.9%）
ImmuCell Corp是一家总部位于美国的动物健康生物技术企业，主要研发、生产和销售以奶牛为主的家畜相关保健与治疗产品，核心产品包括乳腺炎等常见牛类疾病的防治方案，主要服务北美地区的畜牧养殖户和兽医机构。
瓦拉瑞斯有限公司是全球领先的海上钻井承包商，总部位于美国得克萨斯州休斯敦，注册地为百慕大，是全球规模最大的海上钻井及油井钻井服务企业。截至2025年2月，公司共运营52座钻井平台，包含36座海上自升式钻井平台、11艘钻井船以及5座半潜式钻井平台。
ICCC vs VAL — 直观对比
营收规模更大
ICCC
是对方的1.1倍
$5.2M
营收增速更快
VAL
高出414.3%
-8.4%
净利率更高
VAL
高出13800.6%
-2.5%
自由现金流更多
ICCC
多$32.3M
$-34.1M
两年增速更快
VAL
近两年复合增速
3.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5M | $5.2M |
| 净利润 | $-139.7K | $717.5M |
| 毛利率 | 42.9% | -7850.0% |
| 营业利润率 | 0.4% | — |
| 净利率 | -2.5% | 13798.1% |
| 营收同比 | -8.4% | 405.9% |
| 净利润同比 | 80.1% | 436.6% |
| 每股收益（稀释后） | $-0.02 | $10.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICCCVAL
| Q4 25 | — | $5.2M | ||
| Q3 25 | $5.5M | $5.6M | ||
| Q2 25 | $6.4M | $700.0K | ||
| Q1 25 | $8.1M | — | ||
| Q4 24 | $7.8M | $-1.7M | ||
| Q3 24 | $6.0M | $3.9M | ||
| Q2 24 | $5.5M | $4.8M | ||
| Q1 24 | $7.3M | $2.6M |
净利润ICCCVAL
| Q4 25 | — | $717.5M | ||
| Q3 25 | $-139.7K | $188.1M | ||
| Q2 25 | $501.9K | $115.1M | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | — | $133.7M | ||
| Q3 24 | $-701.7K | $64.6M | ||
| Q2 24 | $-1.5M | $149.6M | ||
| Q1 24 | $-437.9K | $25.5M |
毛利率ICCCVAL
| Q4 25 | — | -7850.0% | ||
| Q3 25 | 42.9% | -7142.9% | ||
| Q2 25 | 43.7% | -56428.6% | ||
| Q1 25 | 41.6% | — | ||
| Q4 24 | 36.5% | 24529.4% | ||
| Q3 24 | 26.3% | -11748.7% | ||
| Q2 24 | 22.5% | -9039.6% | ||
| Q1 24 | 31.6% | -17007.7% |
营业利润率ICCCVAL
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 8.8% | — | ||
| Q1 25 | 13.9% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | -9.6% | — | ||
| Q2 24 | -25.3% | — | ||
| Q1 24 | -4.1% | — |
净利率ICCCVAL
| Q4 25 | — | 13798.1% | ||
| Q3 25 | -2.5% | 3358.9% | ||
| Q2 25 | 7.8% | 16442.9% | ||
| Q1 25 | 17.9% | — | ||
| Q4 24 | — | -7864.7% | ||
| Q3 24 | -11.7% | 1656.4% | ||
| Q2 24 | -28.0% | 3116.7% | ||
| Q1 24 | -6.0% | 980.8% |
每股收益（稀释后）ICCCVAL
| Q4 25 | — | $10.13 | ||
| Q3 25 | $-0.02 | $2.65 | ||
| Q2 25 | $0.06 | $1.61 | ||
| Q1 25 | $0.16 | — | ||
| Q4 24 | $0.09 | $1.86 | ||
| Q3 24 | $-0.09 | $0.88 | ||
| Q2 24 | $-0.20 | $2.03 | ||
| Q1 24 | $-0.06 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.9M | $599.4M |
| 总债务越低越好 | $9.5M | — |
| 股东权益账面价值 | $29.8M | $3.2B |
| 总资产 | $45.7M | $5.3B |
| 负债/权益比越低杠杆越低 | 0.32× | — |
8季度趋势，按日历期对齐
现金及短期投资ICCCVAL
| Q4 25 | — | $599.4M | ||
| Q3 25 | $3.9M | $662.7M | ||
| Q2 25 | — | $503.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.8M | $368.2M | ||
| Q3 24 | — | $379.3M | ||
| Q2 24 | $1.3M | $398.3M | ||
| Q1 24 | $960.3K | $494.1M |
总债务ICCCVAL
| Q4 25 | — | — | ||
| Q3 25 | $9.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $8.7M | — | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $9.8M | — | ||
| Q1 24 | $10.2M | — |
股东权益ICCCVAL
| Q4 25 | — | $3.2B | ||
| Q3 25 | $29.8M | $2.4B | ||
| Q2 25 | $29.9M | $2.3B | ||
| Q1 25 | $29.0M | — | ||
| Q4 24 | $27.5M | $2.2B | ||
| Q3 24 | $26.4M | $2.1B | ||
| Q2 24 | $23.5M | $2.2B | ||
| Q1 24 | $24.6M | $2.0B |
总资产ICCCVAL
| Q4 25 | — | $5.3B | ||
| Q3 25 | $45.7M | $4.6B | ||
| Q2 25 | $46.7M | $4.5B | ||
| Q1 25 | $45.6M | — | ||
| Q4 24 | $45.1M | $4.4B | ||
| Q3 24 | $44.4M | $4.3B | ||
| Q2 24 | $41.9M | $4.4B | ||
| Q1 24 | $43.1M | $4.4B |
负债/权益比ICCCVAL
| Q4 25 | — | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.42× | — | ||
| Q1 24 | 0.41× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $72.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-34.1M |
| 自由现金流率自由现金流/营收 | -32.3% | -655.8% |
| 资本支出强度资本支出/营收 | 10.8% | 2044.2% |
| 现金转化率经营现金流/净利润 | — | 0.10× |
| 过去12个月自由现金流最近4个季度 | $715.4K | $159.9M |
8季度趋势，按日历期对齐
经营现金流ICCCVAL
| Q4 25 | — | $72.2M | ||
| Q3 25 | $-1.2M | $198.1M | ||
| Q2 25 | $1.6M | $120.0M | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $-3.1K | $124.6M | ||
| Q3 24 | $-639.3K | $193.0M | ||
| Q2 24 | $581.8K | $11.5M | ||
| Q1 24 | $418.5K | $26.3M |
自由现金流ICCCVAL
| Q4 25 | — | $-34.1M | ||
| Q3 25 | $-1.8M | $128.3M | ||
| Q2 25 | $1.4M | $52.8M | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $-199.3K | $12.9M | ||
| Q3 24 | $-727.7K | $111.1M | ||
| Q2 24 | $471.0K | $-98.7M | ||
| Q1 24 | $348.1K | $-125.0M |
自由现金流率ICCCVAL
| Q4 25 | — | -655.8% | ||
| Q3 25 | -32.3% | 2291.1% | ||
| Q2 25 | 22.4% | 7542.9% | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | -2.6% | -758.8% | ||
| Q3 24 | -12.1% | 2848.7% | ||
| Q2 24 | 8.6% | -2056.3% | ||
| Q1 24 | 4.8% | -4807.7% |
资本支出强度ICCCVAL
| Q4 25 | — | 2044.2% | ||
| Q3 25 | 10.8% | 1246.4% | ||
| Q2 25 | 2.4% | 9600.0% | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 2.5% | -6570.6% | ||
| Q3 24 | 1.5% | 2100.0% | ||
| Q2 24 | 2.0% | 2295.8% | ||
| Q1 24 | 1.0% | 5819.2% |
现金转化率ICCCVAL
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | 3.19× | 1.04× | ||
| Q1 25 | 1.09× | — | ||
| Q4 24 | — | 0.93× | ||
| Q3 24 | — | 2.99× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
